Assessment of myocardial viability and recovery ofthe left ventricular function in postmyocardial infarction patients


Cite item

Full Text

Abstract

Aim. To evaluate prognostic significance of myocardial viability (MV) depending on treatment policy
in postmyocardial infarction (PMI) patients.
Material and methods. The study included 196 patients (172 males, 24 females, age 30-75, mean
age 53 ± 8.6 years). Standard stress dobutamine echocardiography was made 14 ± 6 days (8-21
days) after macrofocal MI. Reperfusion therapy was made in 138 (70%) patients. X-ray contrast coronary
angiography was performed in all the patients as the criterion of the immediate effect of reperfusion
was achievement of residual stenosis of Ml-related coronary artery < 50%. Late after Ml
(18 ± 7 months after Ml) a comparative analysis of the left ventricular function was made in three
groups of patients depending on the clinical response to the treatment. MV criterion was based on a
fall in the index of infarction zone wall movement (IZWM) under low-dose dobutamine stress test reflecting
contractile reserve of the infarction zone (CR). Left ventricular function recovery was judged
by a decrease in initial IZWM index 18 months later vs the initial IZWM 14 days later. Thus contractile
reversibility of the infarction zone (CRIZ) was determined. LV function was also assessed by
the index of left ventricular end diastolic volume (L VED V), by the index of left ventricular end systolic
volume (LVESV), left ventricular ejection fraction (LVEF).
Results. 18 months after MI, CRIZ was higher in group 1 (after effective reperfusion) and group 3 (after
myocardial revascularization) compared to group 2 (medication only): 0.33 ± 0.01, 0.39 ± 0.02
and 0.23 ± 0.01, respectively. LVEDV and LVESV in group 1 and 3 diminished while LVEF increased.
LVEDV in group 2 remained elevated though EF rose considerably.
Conclusion. Recovery of LV contractile function depends much on reestablishment of adequate myocardial
perfusion by reperfusion therapy or myocardial revascularization. Chronic myocardial hypoperfusion
leads to LV remodeling. CRIZ proved a significant prognostic criterion of the IZWM index 18
months after MI only in patients given effective reperfusion therapy.

References

  1. Sharpe N., Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet 1998; 352 (suppl. 1): 13-17.
  2. Bart B. A., Shaw L. K., McCants С. В. et al. Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J. Am. Coll. Cardiol. 1997; 24: 1002-1008.
  3. Better G. A. Myocardial hibernation: a clinician's perspective.Ital. Heart J. 2002; 3: 291-293.
  4. Benzer W., Fritzsche H., Kargl M., Drexel H. Revascularization of the residual viable myocardium improves left ventricular dysfunction in patients after myocardial infarction. Wien. KJin. Wschr. 1999; 111:636-642.
  5. Kofoed К. F., Bangsgaard R., Carstensen S. et al. Prolonged ischemic heart disease and coronary artery bypass - relation to contractile reserve. Eur. J. Cardio-Thorac.Surg. 2002; 21: 417-423.
  6. Afridi I., Grayburn P. A., Panza J. A. et al. Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J. Am. Coll. Cardiol. 1998; 32: 921-926.
  7. Dionbopoulos P., Smart S. C., Sagar К. В. Dobutamine stress echocardiography predicts left ventricular remodeling after acute myocardial infarction. J. Am. Soc. Echocardiogr. 1999; 12: 777-784.
  8. Lombardo A., Lopefrido F., Trani С. et al. Detection of myocardial viability and prediction of recovery dysfunctional myocardium in patients after coronary revascularization by dobutamine stress echocardiography. J. Am. Coll. Cardiol. 1997; 30: 633-640.
  9. Lorusso R., L. Carina C., Ceconi C. et al. Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium. Eur.J. Cardio-Thorac. Surg. 2001; 20: 937-948.
  10. Медведева В. И., Орлова О. И., Шашков Е. Л., Медведев В. Н. Нагрузочная эхокардиография с добутрексом: клиническое и прогностическое значение, побочные эффекты. Тер. арх. 2001; 8: 19-24.
  11. Bigi R., Desideri A., Bax J. J. et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function.Am. J. Cardiol. 2001; 87: 283-288.
  12. Jun Т., Hirono O., Kubota I. et al. Dobutamine stress echocardiography for the diagnosis of myocardial viability. Jpn. Heart J. 2000; 41:435-443.
  13. Hoffmann A., Lethen H., Marvick T. et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J. Am. Coll. Cardiol. 1996; 27: 330-336.
  14. Smart S. C. et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993; 88: 405-415.
  15. Erbel R., Schweizer P., Lambert H. et al. Principle of global left ventricular function analysis. Circulation 1983: 67: 205.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2004 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

© 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies